Simultaneous analysis of cyclophosphamide, doxorubicin and doxorubicinol by liquid chromatography coupled to tandem mass spectrometry

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 852, Issue 1-2, 2007, Pages 545-553

  DiFrancesco, Robin ^a   Griggs, Jennifer J ^b   Donnelly, Julie ^a   DiCenzo, Robert ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Anthracyclines; Assay; Obesity; Pharmacokinetics

Indexed keywords

CHEMOTHERAPY; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATIENT TREATMENT; PLASMA (HUMAN); SEPARATION;

ANTHRACYCLINES; CHEMOTHERAPEUTIC TREATMENT; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

PHARMACOKINETICS;

CYCLOPHOSPHAMIDE; DOXORUBICIN; DOXORUBICINOL;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG STRUCTURE; HUMAN; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; REPRODUCIBILITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VALIDITY;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 34249732069     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.02.033     Document Type: Article

References (25)

1. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000, J. Natl.Cancer Inst. Monogr. (2001) 5.
2. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer, CMAJ 158 (Suppl. 3) (1998) S52.
3. Griggs J.J., Sorbero M.E., and Lyman G.H. Arch. Intern. Med. 65 (2005) 1267
4. Reilly J.J., and Workman P. Cancer Chemother. Pharmacol. 34 (1994) 3
5. Rosner G.L., Hargis J.B., Hollis D.R., Budman D.R., Weiss R.B., Henderson I.C., and Schilsky R.L. J. Clin. Oncol. 11 (1996) 3000
6. Colleoni M., Li S., Gelber R.D., Price K.N., Coates A.S., Castiglione-Gertsch M., Goldhirsch A., and International Breast Cancer Study Group. Lancet 366 (2005) 1108
7. Powis G., Reece P., Ahmann D.L., and Ingle J.N. Cancer Chemother. Pharmacol. 20 (1987) 219
8. Rodvold K.A., Rushing D.A., and Tewksbury D.A. J. Clin. Oncol. 6 (1988) 1321
9. Rosner G.L., Hargis J.B., Hollis D.R., Budman D.R., Weiss R.B., and Henderson I.C. J. Clin. Oncol. 14 (1996) 3000
10. Kobayashi K., and Ratain M.J. Semin. Oncol. 20 (1993) 30
11. Bergh J. Recent Results Cancer Res. 152 (1998) 328
12. Desai R.B., Schwartz M.S., and Matuszewski B.K. J. Chromatogr. Sci. 42 (2004) 317
13. Sadagopan N., Cohen L., Roberts B., Collard W., and Omer C. J. Chromatogr. B 759 (2001) 277
14. Baumann F., Lorenz C., Jaehde U., and Preiss R. J. Chromatogr. B 729 (1999) 297
15. Huitema A.D.R., Tibben M.M., Kerbusch T., Kettenes-van den Bosch J.J., Rodenhuis S., and Beijnen J.H. J. Chromatogr. B 745 (2000) 345
16. Lachâtre F., Marquet P., Ragot S., Gaulier J.M., Cardot P., and Dupuy J.L. J. Chromatogr. B 738 (2000) 281
17. Kümmerle A., Krueger T., Dusmet M., Vallet C., Pan Y., Ris H.B., and Decosterd L.A. J. Pharm. Biomed. Anal. 33 (2003) 475
18. Arnold R.D., Slack J.E., and Straubinger R.M. J. Chromatogr. B 808 (2004) 141
19. Kalhorn T.F., Ren S., Howald W.N., Lawrence R.F., and Slattery J.T. J. Chromatogr. B 732 (1999) p.287
20. GUIDANCE FOR INDUSTRY, Bioanalytical Method Validation, US Department of Health and Human Services, FDA, CDER, CVM, May 2001, available at http://www.fda.gov/cder/guidance/4252fnl.pdf.
21. DiCenzo R., Griggs J., and Forrest A. American College of Clinical Pharmacy Annual Meeting. ST Louis, MO, October 26-29 (2006) (Abstract 410)
22. de Jonge M.E., van Dam S.M., Hillebrand M.J.X., Rosing H., Huitema A.D.R., Rodenhuis S., and Beijen J.H. J. Mass Spectrom. 39 (2004) 262
23. Balfayol L., Guillevin L., Louchahi K., Lortholary O., Bosio A.M., and Fauvelle F. J. Chromatogr. 633 (1995) 395
24. IMMUNOASSAY AND TANDEM MASS SPECTROMETRY: Perspectives on Today's Applications and Tomorrow's Opportunities, Teleconference sponsored by American Association for Clinical Chemistry, June 16, 2006, Data from CAP PT program for cyclosporine analysis, slide 19, Steven Soldin, Ph.D.
25. Andersen A., Warren D.J., and Slordal L. Ther. Drug Monit. 15 (1993) 455